JNJ-47965567
SIGMA/SML1708 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 1428327-31-4
Empirical Formula (Hill Notation): C28H32N4O2S
Molecular Weight: 488.64
MDL Number: MFCD28334214
Linear Formula: C28H32N4O2S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C28H32N4O2S/c33-26(25- |
| InChI key | XREFXUCWSYMIOG-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | O=C(NCC1(CCOCC1)N2CCN(C3= |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | 2-8°C |
| Biochem/physiol Actions: | JNJ-47965567 is a potent P2X7 antagonist with high affinity for the rat receptor (pKi = 8.7). It is centrally available after systemic injection with a superior brain:plasma distribution compared to other available P2X7 antagonists. JNJ-47965567 was shown to suppress epileptic seizures in a mouse model of epilepsy. It appears to have a disease modifying effect since spontaneous seizure rates did not increase once treatment with JNJ-477965567 was stopped. |
| Biochem/physiol Actions: | P2X7 antagonist |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |

